Does surface preparation alter ALA uptake in superficial non-melanoma skin cancer in vivo?

Photodermatology Photoimmunology and Photomedicine

Volumn 24, Issue 2, 2008, Pages 72-75

  Moseley, Harry ^a   Brancaleon, Lorenzo ^a,b   Lesar, Andrea E ^a   Ferguson, James ^a   Ibbotson, Sally H ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

ALA; Aminolaeveulinic acid; Fluorescence; PDT; Photodynamic therapy; Skin cancer

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG UPTAKE; FLUORESCENCE SPECTROSCOPY; HUMAN; IN VIVO STUDY; LASER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN ABRASION; SKIN SURFACE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CARCINOMA, BASAL CELL; CURETTAGE; FEMALE; FLUORESCENCE; HUMANS; MALE; MIDDLE AGED; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 41149148211     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2008.00338.x     Document Type: Article

References (12)

1. Biro D. Choosing the right modality to treat non-melanoma skin cancer. Skin Aging 1999; 7: 40-47.
2. Bissonnette R, Shapiro J, Zeng H, Mclean DI, Lui H. Topical photodynamic therapy with 5-aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areata. Br J Dermatol 2000; 143: 1032-1035.
3. Edell ES, Cortese DA. Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest 1992; 102: 1319-1322.
4. Peng Q, Warloe T, Berg K, et al. 5-amonolevulinic acid-based photodynamic therapy. Clincal research and future challenges. Cancer 1997; 79: 2282-2308.
5. Andersson-Engels S, Canti G, Cubeddu R, et al. Preliminary evaluation of two fluorescence imaging methods for the detection and the delineation of basal cell carcinomas of the skin. Lasers Surg Med 2000; 26: 76-82.
6. Campbell DL, Gudgin-Dickson EF, Forkert PG, Pottier RH, Kennedy JC. Detection of early stages of carcinogenesis in adenomas of murine lung by 5-aminolevulinic acid-induced protoporphyrin IX fluorescence. Photochem Photobiol 1996; 64: 676-682.
7. Cubeddu R, Pifferi A, Taroni P, et al. Fluorescence lifetime imaging: An application to the detection of skin tumours. IEEE J Selec Topics Quant Elect 1999; 5: 923-928.
8. Lange N, Jichlinski P, Zellweger M, et al. Photodetection of early human bladder cancer based on the fluorescence of 5 aminolaevulinic acid hexylester-induced protoporphyrin IX: A pilot study. Br J Cancer 1999; 80: 185-193.
9. Monnier P, Savary M, Fontolliet C, et al. Photodetection and photodynamic therapy of 'early' squamous cell carcinomas of the pharynx, oesophagus and tracheo-bronchial tree. Laser Med Sci 1990; 5: 149-169.
10. Tian WD, Brancaleon L, Gillies R, Kollias N. Aging and effects of ultraviolet A exposure may be quantified by fluorescence excitation spectroscopy in vivo. J Invest Dermatol 2001; 116: 840-845.
11. Hofmann UB, Westphal JR, van Muijen GNP, Ruiter DJ. Matrix metalloproteinases in human melanoma. J Invest Dermatol 2000; 115: 337-344.
12. Varani J, Hattori Y, Chi Y, et al. Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: Comparison with normal skin. Br J Cancer 2000; 82: 657-665.